Characterization of a bidirectional promoter shared between two human genes related to aging:: SIRT3 and PSMD13

被引:72
作者
Bellizzi, D. [1 ]
Dato, S. [1 ]
Cavalcante, P. [1 ]
Covello, G. [1 ]
Di Cianni, F. [1 ]
Passarino, G. [1 ]
Rose, G. [1 ]
De Benedictis, G. [1 ]
机构
[1] Univ Calabria, Dept Cell Biol, I-87030 Arcavacata Di Rende, Italy
关键词
SIRT3; PSMD13; bidirectional promoter; human longevity;
D O I
10.1016/j.ygeno.2006.09.004
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The human SIRT3 gene contains an intronic VNTR enhancer whose variability is correlated with life span. The SIRT3 5' flanking region encompasses the PSMD13 gene encoding the p40.5 regulator subunit of the 26S proteasome. Proteasome is a multicatalytic proteinase whose function declines with aging. SIRT3 and PSMD13. are linked in a head-to-head configuration (788-bp intergenic region). The molecular configuration of two genes that are both related to aging prompted us to search for shared regulatory mechanisms between them. Transfection experiments carried out in HeLa cells by deletion mutants of the PSMD13-SIRT3 intergenic region showed a complex pathway of coregulation acting in both directions. Furthermore, linkage disequilibrium (LD) analyses carried out in a sample of 710 subjects (18-108 years of age) screened for A2163IG (markerof PSMD13), and for G477T and VNTRintron5 (markers of SIRT3), revealed high LD, with significantly different PSMD13-SIRT3 haplotype pools between samples of centenarians and younger people. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:143 / 150
页数:8
相关论文
共 41 条
  • [1] Bidirectional gene organization: A common architectural feature of the human genome
    Adachi, N
    Lieber, MR
    [J]. CELL, 2002, 109 (07) : 807 - 809
  • [2] Lipoprotein genotype and conserved pathway for exceptional longevity in humans
    Atzmon, G
    Rincon, M
    Schechter, CB
    Shuldiner, AR
    Lipton, RB
    Bergman, A
    Barzilai, N
    [J]. PLOS BIOLOGY, 2006, 4 (04) : 562 - 569
  • [3] Head-to-head debate: Is there a program for aging? Is aging programed?
    Austad, SN
    [J]. AGING CELL, 2004, 3 (05) : 249 - 251
  • [4] A novel VNTR enhancer within the SIRT3 gene, a human homologue of SIR2, is associated with survival at oldest ages
    Bellizzi, D
    Rose, G
    Cavalcante, P
    Covello, G
    Dato, S
    De Rango, F
    Greco, V
    Maggiolini, M
    Feraco, E
    Mari, V
    Franceschi, C
    Passarino, G
    De Benedictis, G
    [J]. GENOMICS, 2005, 85 (02) : 258 - 263
  • [5] The human transcriptome map:: Clustering of highly expressed genes in chromosomal domains
    Caron, H
    van Schaik, B
    van der Mee, M
    Baas, F
    Riggins, G
    van Sluis, P
    Hermus, MC
    van Asperen, R
    Boon, K
    Voûte, PA
    Heisterkamp, S
    van Kampen, A
    Versteeg, R
    [J]. SCIENCE, 2001, 291 (5507) : 1289 - +
  • [6] Proteasome dysfunction in mammalian aging: Steps and factors involved
    Chondrogianni, N
    Gonos, ES
    [J]. EXPERIMENTAL GERONTOLOGY, 2005, 40 (12) : 931 - 938
  • [7] EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921
  • [8] Proteasome function in aging and oxidative stress: Implications in protein maintenance failure
    Farout, L
    Friguet, B
    [J]. ANTIOXIDANTS & REDOX SIGNALING, 2006, 8 (1-2) : 205 - 216
  • [9] FISCHER KD, 1993, J BIOL CHEM, V268, P23915
  • [10] Do men and women follow different trajectories to reach extreme longevity?
    Franceschi, C
    Motta, L
    Valensin, S
    Rapisarda, R
    Franzone, A
    Berardelli, M
    Motta, M
    Monti, D
    Bonafè, M
    Ferrucci, L
    Deiana, L
    Pes, GM
    Carru, C
    Desole, MS
    Barbi, C
    Sartoni, G
    Gemelli, C
    Lescai, F
    Olivieri, F
    Marchegiani, F
    Cardelli, M
    Cavallone, L
    Gueresi, P
    Cossarizza, A
    Troiano, L
    Pini, G
    Sansoni, P
    Passeri, G
    Lisa, R
    Spazzafumo, L
    Amadio, L
    Giunta, S
    Stecconi, R
    Morresi, R
    Viticchi, C
    Mattace, R
    De Benedictis, G
    Baggio, G
    [J]. AGING-CLINICAL AND EXPERIMENTAL RESEARCH, 2000, 12 (02) : 77 - 84